{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:32:38Z","timestamp":1773516758383,"version":"3.50.1"},"reference-count":14,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>College of American Pathologists (CAP) surveys are used to establish national benchmarks for laboratory parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate changes in laboratory human papillomavirus (HPV) testing patterns in laboratories incorporating HPV testing with Papanicolaou tests in 2012.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Data were analyzed from the CAP HPV Supplemental Questionnaire distributed to 1771 laboratories participating in either CAP HPV or CAP Papanicolaou proficiency testing in 2013.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1022 laboratories (58%) responded. There were more high-risk (HR) HPV tests performed per institution as compared to previous surveys. There were more HPV tests performed within an institution as compared to previous surveys. Hybrid Capture 2 (HC2) remains the most common method (42.4%, 239 of 564); Cervista and cobas methods are used in 37.2% (210 of 564) and 14.9% (84 of 564) of laboratories, respectively. Human papillomavirus testing is offered as a reflex test after a Papanicolaou test result of atypical squamous cells of undetermined significance (ASC-US) in 89.6% of laboratories (476 of 531); as a cotest for women aged 30 years and older in 60.3% (404 of 531); as reflex testing after atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H) in 42.7% (320 of 531); and as reflex testing after atypical glandular cells (AGC) in 27.3% (145 of 531). The HPV-positive rates for ASC-US and ASC-H were similar in 2012 and 2006. Cervista (49.2%, 88 of 179) and Roche cobas (27.4%, 49 of 179) are the most common methods used for genotyping. Most laboratories use the CAP Human Papillomavirus for Cytology Program for proficiency testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There was an increase in annual volume of HR-HPV testing with a shift toward in-house HR-HPV testing. Genotyping volumes also increased. HC2 and Cervista are most commonly used, with an increasing volume of Roche cobas testing. The most common indication for HPV testing among all laboratories was ASC-US reflex testing, but an increase in HPV cotesting was observed. The data provide an update into persisting and newer trends in HPV testing practices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2014-0393-cp","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T16:31:05Z","timestamp":1417451465000},"page":"757-761","source":"Crossref","is-referenced-by-count":26,"title":["Human Papillomavirus Testing and Reporting Rates in 2012: Results of a College of American Pathologists National Survey"],"prefix":"10.5858","volume":"139","author":[{"given":"Chengquan","family":"Zhao","sequence":"first","affiliation":[{"name":"From the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Zhao); the Department of Esoteric Testing, AmeriPath Indiana, Indianapolis (Dr Moriarty); the Department of Pathology, PeaceHealth Laboratories, Vancouver, Washington (Dr Ghofrani); Clinical Sciences, University of Central Florida, Orlando (Dr Husain); the Department of Pathology, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann T.","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohiedean","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujtaba","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary H.","family":"Tambouret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Laucirica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Laser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idris T.","family":"Ocal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhona J.","family":"Souers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna K.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"Crothers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"issue":"4","key":"2020081217365501400_i1543-2165-139-6-757-b01","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/dc.2840110416","article-title":"Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors","volume":"11","author":"Davey","year":"1994","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"2020081217365501400_i1543-2165-139-6-757-b02","first-page":"440","article-title":"Atypical squamous cells of undetermined significance: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology","volume":"120","author":"Davey","year":"1996","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"2020081217365501400_i1543-2165-139-6-757-b03","first-page":"903","article-title":"Terminology and specimen adequacy in cervicovaginal cytology: the College of American Pathologists Interlaboratory Comparison Program experience","volume":"116","author":"Davey","year":"1992","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2020081217365501400_i1543-2165-139-6-757-b04","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5858\/2000-124-0203-AECASA","article-title":"Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology","volume":"124","author":"Davey","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"2020081217365501400_i1543-2165-139-6-757-b05","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.5858\/2004-128-1224-BIARRP","article-title":"Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology","volume":"128","author":"Davey","year":"2004","journal-title":"Arch Pathol Lab Med"},{"issue":"16","key":"2020081217365501400_i1543-2165-139-6-757-b06","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.287.16.2120","article-title":"2001 consensus guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"2020081217365501400_i1543-2165-139-6-757-b07","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening","volume":"103","author":"Wright","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2020081217365501400_i1543-2165-139-6-757-b08","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"2020081217365501400_i1543-2165-139-6-757-b09","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"16","author":"Saslow","year":"2012","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"2020081217365501400_i1543-2165-139-6-757-b10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"7","key":"2020081217365501400_i1543-2165-139-6-757-b11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"issue":"8","key":"2020081217365501400_i1543-2165-139-6-757-b12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.5858\/2008-132-1290-HPTARR","article-title":"Human papillomavirus testing and reporting rates: practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006","volume":"132","author":"Moriarty","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"2020081217365501400_i1543-2165-139-6-757-b13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/dc.20674","article-title":"A rock and a hard place: HPV testing and financial gain","volume":"35","author":"Moriarty","year":"2007","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"2020081217365501400_i1543-2165-139-6-757-b14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/AOG.0b013e3182210034","article-title":"Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among US health care providers","volume":"118","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/6\/757\/1614494\/arpa_2014-0393-cp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/6\/757\/1614494\/arpa_2014-0393-cp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:34:16Z","timestamp":1764790456000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/139\/6\/article-p757.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":14,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2014-0393-cp","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}